For decades, women’s pain has been dismissed as hysteria, anxiety, or mere exaggeration—a historical pattern that has not only persisted but evolved into something far more insidious when it comes to long COVID. While the world grappled with the immediate devastation of the pandemic, a quieter crisis unfolded in the shadows: the systemic erasure of women’s long COVID symptoms from research, policy, and public discourse. The data is damning. Study after study reveals that women are not only more likely to develop long COVID but are also more likely to have their symptoms trivialized, misdiagnosed, or outright ignored by the medical establishment. This isn’t just a failure of science—it’s a failure of empathy, a betrayal of trust, and a stark reminder that when it comes to women’s health, the system is rigged against them.
The Invisible Epidemic: Why Women Bear the Brunt of Long COVID
Women account for roughly 80% of long COVID cases worldwide, yet their symptoms—fatigue, brain fog, post-exertional malaise, gynecological complications—are often relegated to the realm of the “unmeasurable” or the “subjective.” This isn’t a coincidence. It’s the result of a medical paradigm that has long treated women’s bodies as deviations from the male norm. Long COVID research, like so much of medicine before it, operates on the assumption that the male body is the default, leaving women’s experiences sidelined in clinical trials, diagnostic criteria, and treatment protocols. The consequences are dire: women wait longer for diagnoses, are prescribed antidepressants instead of proper care, and are told their symptoms are “all in their heads.” Meanwhile, their bodies continue to unravel in ways that defy the narrow frameworks of a system that refuses to see them.
Consider the language used to describe long COVID in women. Terms like “mystery illness,” “medically unexplained,” and “functional” are code for “we don’t know what’s wrong with you, and we don’t care to find out.” This dismissal is not just frustrating—it’s life-threatening. Women with long COVID report being gaslit by doctors who insist their symptoms are stress-related or hormonal, only to later discover they have autonomic dysfunction, mitochondrial damage, or autoimmune flare-ups. The irony? Many of these conditions were already known to disproportionately affect women—conditions like myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and postural orthostatic tachycardia syndrome (POTS)—yet long COVID research has been slow to connect the dots. Why? Because women’s suffering has never been a priority.
The Research Gap: A Deliberate Blind Spot or a Symptom of Systemic Bias?
The lack of robust long COVID research on women isn’t just an oversight—it’s a structural failure. Clinical trials for COVID-19 treatments and vaccines have historically underrepresented women, particularly women of color, older women, and those with pre-existing conditions. When women *are* included, their data is often buried in sub-analyses or dismissed as “noise” in the results. This isn’t accidental; it’s baked into the foundations of medical research. The NIH, for example, only began requiring the inclusion of women in clinical trials in 1993—less than 30 years ago. Before that, women were excluded on the flimsy pretext that their hormonal cycles would “complicate” the data. Today, the same logic is applied to long COVID: women’s symptoms are deemed too variable, too complex, too *female* to warrant serious study.
But here’s the kicker: the symptoms women experience—chronic pain, gastrointestinal distress, menstrual irregularities, cognitive dysfunction—are precisely the ones that don’t fit neatly into the biomedical model. Medicine has long privileged measurable, quantifiable outcomes over the messy, subjective realities of women’s lives. So when women report that their periods have become unbearable, that sex is now painful, or that they can no longer work because their brains feel like they’re wrapped in cotton, the system has no framework to accommodate them. Instead, they’re told to “rest,” to “manage their stress,” to “accept that this is just how it is now.” This isn’t science. It’s gaslighting.
From Gaslighting to Advocacy: The Women Fighting Back
Yet, as with so many injustices, women are refusing to be silent. Grassroots movements led by long COVID patients—disproportionately women—have emerged to demand recognition, research, and care. Organizations like the Long COVID Justice Project and the #MEAction Network have become battlegrounds where women are rewriting the narrative, insisting that their symptoms are not just real but urgent. These activists are not just asking for better research; they’re demanding a fundamental shift in how medicine approaches women’s health. They’re calling out the bias in diagnostic criteria, the lack of female representation in studies, and the outright dismissal of their experiences. And slowly, they’re winning.
One of the most powerful tools in their arsenal is the power of storytelling. When women share their long COVID journeys—raw, unfiltered, and unapologetic—they shatter the illusion that this is a “mysterious” illness. They expose the cracks in the system. They force researchers to confront the fact that what they’ve been calling “atypical” is actually the norm for half the population. Social media has become a megaphone for these voices, with hashtags like #LongCovid and #MECFS trending as women document their struggles in real time. This isn’t just awareness-raising; it’s a revolution in how we understand disease.
The Path Forward: What Would Justice Look Like?
So what would it take to fix this? The answer is simple, though the execution will be anything but: women must be centered in long COVID research. Not as an afterthought, not as a footnote, but as the primary focus. This means:
- Gender-inclusive clinical trials: Long COVID studies must actively recruit women, particularly those from marginalized communities, and ensure their data is analyzed separately—not lumped into a catch-all category labeled “other.”
- Interdisciplinary research: Long COVID doesn’t fit neatly into one medical specialty. It demands collaboration between immunologists, neurologists, gynecologists, and psychologists—fields where women’s health has historically been treated as an afterthought.
- Patient-led research: Women with long COVID must be at the forefront of designing studies, setting agendas, and interpreting results. Their lived experiences are not just valuable—they’re essential.
- Policy changes: Governments and health organizations must fund research specifically focused on women’s long COVID symptoms and ensure that diagnostic criteria reflect the realities of female patients.
But justice won’t come from policy alone. It will come from a cultural reckoning—a recognition that women’s pain has been ignored for too long, and that long COVID is just the latest manifestation of a much older, much deeper problem. The medical establishment must confront its biases head-on, and the public must demand better. This isn’t just about long COVID. It’s about the kind of world we want to live in: one where women’s suffering is met with curiosity, not contempt; with care, not dismissal; with action, not apathy.
The women living with long COVID are not asking for pity. They’re asking for the world to finally see them. It’s time we did.
Leave a Comment